Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
Abstract Purpose: PD-L1 is the main ligand for the immune inhibitory receptor PD-1. This ligand is frequently expressed by melanoma cells. In this study, we investigated whether...
Publications
2 shownInterferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
PD-L1 and PD-L2 are ligands for the PD-1 immune inhibiting checkpoint that can be induced in tumors by interferon exposure, leading to immune evasion. This process is important ...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,096
- Institution
- University of California, Los Angeles
External Links
Identifiers
- ORCID
- 0000-0002-3618-9533
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.